General Information of the Compound
Compound ID |
CP0507779
|
||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Compound Name |
(+/-)2-(3-Methoxy-phenyl)-1-methyl-ethylamine
Show/Hide
|
||||||||||||||||||
Synonyms |
1-(3-Methoxyphenyl)-2-propanamine #
1-(3-methoxyphenyl)-2-propylamine
1-(3-methoxyphenyl)propan-2-amine
17862-85-0
17862-91-8
2-(3-Methoxy-phenyl)-1-methyl-ethylamine
2-(3-Methoxyphenyl)-1-methylethylamine
3-Methoxyamphetamine
3-methoxyamphetamine -
AC1L47YE
AKOS000157039
AKOS022196418
BDBM50024211
Benzeneethanamine, 3-methoxy-alpha-methyl-
CHEMBL16247
CTK0H8604
MB01562
MCULE-6670391418
NCI60_042089
NCIOpen2_006073
SCHEMBL269071
VEJWNIYARKAHFI-UHFFFAOYSA-N
meta-Methoxyamphetamine
Show/Hide
|
||||||||||||||||||
Structure |
|
||||||||||||||||||
Formula |
C10H15NO
|
||||||||||||||||||
Molecular Weight |
165.236
|
||||||||||||||||||
Canonical SMILES |
COc1cccc(CC(C)N)c1
Show/Hide
|
||||||||||||||||||
InChI |
InChI=1S/C10H15NO/c1-8(11)6-9-4-3-5-10(7-9)12-2/h3-5,7-8H,6,11H2,1-2H3
Show/Hide
|
||||||||||||||||||
InChIKey |
VEJWNIYARKAHFI-UHFFFAOYSA-N
|
||||||||||||||||||
CAS |
17862-91-8
17862-85-0
|
||||||||||||||||||
Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
PubChem ID | |||||||||||||||||||
ChEMBL ID |
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01492, 5-hydroxytryptamine receptor 2A
Protein ID: PT01480, 5-hydroxytryptamine receptor 2C
Clinical Information about the Compound